Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1. [electronic resource]
Producer: 20170926ISSN:- 1098-5514
- AIDS Vaccines -- immunology
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibody-Dependent Cell Cytotoxicity -- immunology
- Cell Line
- Eye Diseases -- prevention & control
- Female
- HIV Envelope Protein gp120 -- genetics
- Herpes Simplex -- immunology
- Humans
- Killer Cells, Natural -- immunology
- Leukocytes, Mononuclear -- immunology
- Lymphocyte Activation -- immunology
- Mice
- Mice, Inbred BALB C
- Receptors, Tumor Necrosis Factor, Member 14 -- immunology
- Simplexvirus -- genetics
- Viral Envelope Proteins -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.